The effects of angiopoietin-2 on the growth of tongue carcinoma

British Journal of Oral and Maxillofacial Surgery

Volumn 47, Issue 1, 2009, Pages 14-19

  Chen, hai hong ^a   Shi, Zhou jin ^b   Wang, Shen qing ^a   Wu, Qiu liang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenesis; Angiopoietin 2; Inhibit; Tongue carcinoma

Indexed keywords

ANGIOPOIETIN 2; LIPOSOME;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL LINE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TONGUE CARCINOMA;

ANGIOGENESIS INHIBITORS; ANGIOPOIETIN-2; ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, TIE-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TONGUE NEOPLASMS; TRANSFECTION;

EID: 58149359377     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2008.06.008     Document Type: Article

References (24)

1. Folkman J., and Klagsbrun M. Angiogenic factors. Science 235 (1987) 442-447
2. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82 (1990) 4-6
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 (1995) 27-31
4. Kang S.M., Onoda N., Ogawa M., Kato Y., Sawada T., and Chung K.H. Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. Cancer 86 (1999) 566-571
5. Saito H., Tsujitani S., Kondo A., Ikeguchi M., Maeta M., and Kaibara N. Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma. Surgery 125 (1999) 195-201
6. Weidner N., Carroll P.R., Flax J., Blumenfeld W., and Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143 (1993) 401-409
7. Davis S., Aldrich T.H., Jones P.F., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (1996) 1161-1169
8. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
9. Suri C., McClain J., Thurston G., et al. Increased vascularisation in mice overexpressing angiopoietin-1. Science 282 (1998) 468-471
10. Papapetropoulos A., Garcia-Cardena G., Dengler T.J., Maisonpierre P.C., Yancopoulos G.D., and Sessa W.C. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 79 (1999) 213-223
11. Etoh T., Inoue H., Tanaka S., Barnard G.F., Kitano S., and Mori M. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61 (2001) 2145-2153
12. Zhang Z.X., and Xu Y.J. Expression of angiopoietin-2 in non-small cell lung cancer. J Hua Zhong Univ Sci Technolog Med Sci 23 (2003) 362-364
13. Sfiligoi C., de Luca A., Cascone I., et al. Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 103 (2003) 466-474
14. Koga K., Todaka T., Morioka M., et al. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res 61 (2001) 6248-6254
15. Hata K., Nakayama K., Fujiwaki R., Katabuchi H., Okamura H., and Miyazaki K. Expression of the angiopoietin-1, angiopoietin-2, Tie-2, and vascular endothelial growth factor gene in epithelial ovarian cancer. Gynecol Oncol 93 (2004) 215-222
16. Ahmad S.A., Liu W., Jung Y.D., et al. The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res 61 (2001) 1255-1259
17. Tanaka S., Mori M., Sakamoto Y., Makuuchi M., Sugimachi K., and Wands J.R. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest 103 (1999) 341-345
18. Yu Q., and Stamenkovic I. Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am J Pathol 158 (2001) 563-570
19. Lee O.H., Fueyo J., Xu J., et al. Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia 8 (2006) 419-428
20. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
21. Peters K.G. Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel. Circ Res 83 (1998) 342-343
22. Machien M.R., Knedla A., Knoth R., Wagner S., Neuschl E., and Plate K.H. Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am J Pathol 165 (2004) 1557-1570
23. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1: a ligand for the Tie-2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
24. Sato T.N., Tozawa Y., Deutsch U., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376 (1995) 70-74